Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Melmark is a U.S. nonprofit human services organization that provides evidence-based special education, residential, vocational, therapeutic, training, and research services for children and adults with autism spectrum disorder and other intellectual, developmental, neurological, and genetic conditions. The organization operates service divisions in Pennsylvania, New England, and the Carolinas, with corporate offices in Berwyn, Pennsylvania. Melmark's programs are grounded in applied behavior analysis and are designed for individuals with complex clinical and educational needs. Rather than developing drugs or biologics, Melmark delivers direct care, education, and supportive services, and it also engages in professional development, advocacy, and research activities. The organization appears to be an active, mission-driven healthcare and education provider rather than a biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Melmark.